US › Healthcare

Orthofix Medical Inc (OFIX)

US · Healthcare · Medical Devices

$8.64-2.92%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$210.9M

Revenue YoY

+3.8%

Net profit

$-15.8M

EPS

$-0.39

EPS estimate

$-0.46

Net margin

-7.5%

EPS came in at -0.39 against a street estimate of -0.46 — a beat of 15.2%.

Key statistics

Market cap

$361.0M

Forward P/E

500.0

P/B

0.85

Book value

$10.54

EPS (TTM)

$-1.52

52-week high

$16.99

52-week low

$8.62

50-day MA

$10.61

200-day MA

$12.18

Beta

0.65

Analyst view

Analysts rate Orthofix Medical Inc a buy (3 buy, 2 hold, 0 sell out of 5) with an average price target of $13.00.

Shareholding

Insiders

2.17%

Institutions

95.16%

Largest institutional holders

Fund	Stake
Engine Capital Management LP	11.23%
Juniper Investment Co, LLC	10.91%
Rubric Capital Management LP	9.14%
Paradigm Capital Management, Inc.	8.10%
BlackRock Inc	7.88%
Armistice Capital, LLC	6.63%
Vanguard Capital Management, LLC	4.06%
Geode Capital Management, LLC	2.31%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Orthofix Medical Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.